Publications in collaboration with researchers from Universidad Complutense de Madrid (37)

2022

  1. A comprehensive map of microbial biomarkers along the gastrointestinal tract for celiac disease patients

    Frontiers in Microbiology, Vol. 13

2020

  1. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella

    Medical Mycology, Vol. 58, Núm. 1, pp. 83-92

  2. Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  3. Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  4. Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))

    Clinical Microbiology and Infection

2019

  1. Does the composition of polystyrene trays affect candida spp. biofilm formation?

    Medical Mycology, Vol. 57, Núm. 4, pp. 504-509

  2. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 607-614

2018

  1. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

  2. Is biofilm production a prognostic marker in adults with candidaemia?

    Clinical Microbiology and Infection, Vol. 24, Núm. 9, pp. 1010-1015

  3. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect

    Clinical Microbiology and Infection, Vol. 24, Núm. 12, pp. 1343.e1-1343.e4

  4. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

    Medical Mycology, Vol. 56, Núm. 7, pp. 903-906

  5. Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 3

  6. Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 6

2017

  1. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

  2. Frequency of the paradoxical effect measured using the EUCAST procedure with micafungin, anidulafungin, and caspofungin against Candida species isolates causing candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 1

  3. In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

  4. Las placas de agar dextrosado de Sabouraud con fluconazol no son útiles para la detección de resistencia en Candida albicans

    Revista Espanola de Quimioterapia, Vol. 30, Núm. 2, pp. 127-130

  5. The etest performed directly on blood culture bottles is a reliable tool for detection of fluconazole-resistant Candida albicans isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

  6. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 1969-1976

2016

  1. Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in Echinocandin-Resistant yeast species

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3579-3586